Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
2.952
-0.228 (-7.18%)
Nov 21, 2024, 3:56 PM EST - Market closed
Marker Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 26 | 49 | 23 | 79 | 70 | 132 | |
| Market Cap Growth | -37.09% | 115.29% | -71.23% | 13.36% | -47.12% | -47.70% | |
| Enterprise Value | 19 | 31 | 12 | 42 | 55 | 84 | |
| Last Close Price | 3.18 | 5.50 | 2.66 | 9.50 | 14.50 | 28.80 | |
| PS Ratio | 5.25 | 14.77 | 6.46 | 63.57 | 149.18 | 617.67 | |
| PB Ratio | 3.80 | 3.48 | 1.16 | 1.79 | 2.55 | 2.99 | |
| P/TBV Ratio | 3.38 | 3.48 | 1.16 | 1.79 | 2.55 | 2.99 | |
| EV/Sales Ratio | 3.59 | 9.49 | 3.51 | 34.02 | 117.63 | 392.78 | |
| Debt / Equity Ratio | - | - | - | 0.27 | 0.45 | 0.01 | |
| Asset Turnover | 0.36 | 0.13 | 0.07 | 0.02 | 0.01 | 0.00 | |
| Quick Ratio | 2.82 | 5.25 | 1.82 | 3.28 | 3.49 | 22.06 | |
| Current Ratio | 3.15 | 5.57 | 2.14 | 3.56 | 3.81 | 22.83 | |
| Return on Equity (ROE) | -79.76% | -83.47% | -62.20% | -117.42% | -80.37% | -41.44% | |
| Return on Assets (ROA) | -41.92% | -35.36% | -24.12% | -43.38% | -39.26% | -25.95% | |
| Return on Capital (ROIC) | -52.75% | -54.16% | -32.79% | -51.70% | -42.90% | -27.10% | |
| Earnings Yield | -34.17% | -16.85% | -131.80% | -53.05% | -41.22% | -16.27% | |
| FCF Yield | -30.22% | -33.63% | -118.77% | -38.52% | -42.06% | -14.17% | |
| Buyback Yield / Dilution | -2.63% | -5.49% | -9.16% | -62.64% | -3.19% | -138.78% | |
| Total Shareholder Return | -2.63% | -5.49% | -9.16% | -62.64% | -3.19% | -138.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.